Already
Inside You

Section I

The Inventory

You are already contaminated. This is not a prediction or a warning about the future. It is a finding replicated across dozens of independent laboratories on every inhabited continent. Microplastics — fragments of synthetic polymer less than five millimetres across, many of them far smaller — have been discovered in human blood, urine, breast milk, semen, the meconium of newborns, lymph nodes, heart tissue, lung tissue, colon tissue, placenta, testicles, ovarian follicular fluid, and brain.

The scale of the contamination source is almost too large to hold in mind. Humans manufactured roughly 460 million tonnes of plastic in 2019. Since the 1950s, an estimated 8.3 billion metric tonnes have been produced in total — the vast majority never recycled, still in the environment, fragmenting into progressively smaller pieces. A plastic bag does not disappear. It becomes ten thousand particles, then a million, then more, migrating into soil, water, air, and eventually into the tissues of every organism alive on this planet.

The commonly cited figure — that the average person ingests approximately five grams of microplastic per week, equivalent to the weight of a credit card — comes from a 2019 World Wildlife Fund study conducted by the University of Newcastle. The estimate has been disputed on methodological grounds, and subsequent work has produced lower numbers for ingestion specifically. What has not been disputed, in any peer-reviewed literature, is the presence of plastic in every human tissue category studied.

Beyond ingestion, humans inhale microplastics. Airborne plastic fibres shed from synthetic textiles, road tyre abrasion, degraded packaging, and industrial emissions are present in indoor and outdoor air at measurable concentrations worldwide. Urban environments show higher airborne plastic loads. The lungs are not a barrier; they are another entry point.

Section II

The Barriers That Failed

Human physiology evolved protective barriers over hundreds of millions of years. The gut epithelium screens what enters the bloodstream. The blood-brain barrier (BBB) — a specialised mesh of tightly packed endothelial cells lining the brain's blood vessels, reinforced by astrocytic end-feet — is among the most selective biological filters known: it blocks most pathogens, toxins, and the majority of pharmaceutical drugs. The blood-testis barrier is considered the tightest barrier in the body, evolved to protect developing sperm cells from immune destruction during their extended maturation. The placenta acts as a selective exchange membrane between maternal and foetal circulation.

All of these barriers have now been found to contain, or to have been crossed by, microplastics and nanoplastics. This is not a fringe finding. It has been reproduced independently across multiple research groups and published in the journals that matter most.

Size governs mechanism. Microplastics (1 micrometre to 5 mm) can enter cells and tissues through mechanical abrasion and endocytosis — the same pathway cells use to ingest nutrients and debris. Nanoplastics (below 1 micrometre) behave differently: small enough to cross lipid bilayers and move between cells through pathways unavailable to larger particles. It is nanoplastics specifically that have been detected inside neural tissue and on the foetal side of human placentas — in the circulation of the unborn.

The particles do not arrive alone. Plastic manufactured for commercial use contains dozens of chemical additives: phthalates and bisphenol A (BPA) are plasticisers added to improve flexibility; both are established endocrine disruptors, capable of mimicking or blocking hormonal signals at concentrations measured in parts per billion. A plastic particle that crosses the blood-testis barrier carries these chemical passengers with it. The reproductive system has never evolved a defence against this particular combination of physical infiltration and chemical disruption.

In male animal models, microplastic exposure has been linked to impaired spermatogenesis — reduced sperm count, diminished motility, and abnormal morphology. In females, studies have documented ovarian atrophy, endometrial dysfunction, and placental fibrosis. The equivalent human epidemiological data is still accumulating, but the animal findings have been reproduced independently enough that researchers are no longer treating them as preliminary.

Section III

The Evidence So Far

The most consequential human study to date appeared in the New England Journal of Medicine on March 7, 2024. A research team led by Raffaele Marfella at the University of Campania Luigi Vanvitelli in Naples enrolled 257 patients undergoing carotid endarterectomy — surgical removal of fatty deposits blocking the carotid arteries — and analysed the excised tissue using pyrolysis–gas chromatography–mass spectrometry: a technique capable of identifying specific plastic polymers by their thermal decomposition signatures.

58.4% of patients — 150 of 257 — had detectable polyethylene in their arterial plaque. 12.1% also had measurable polyvinyl chloride. The patients were then followed for a mean of 34 months and monitored for major cardiovascular events: heart attack, stroke, or death from any cause.

The mechanism is not yet fully established. Microplastics in arterial plaque may worsen inflammation — the primary driver of plaque instability and rupture — through physical irritation of endothelial tissue, by acting as a scaffold that accelerates foam cell formation, or by releasing pro-inflammatory chemical leachates. The effect may be additive with existing cardiovascular risk factors, compounding the danger in patients who are already vulnerable.

On the neurological side, the Nature Medicine 2024 paper found not only higher plastic concentrations in brain tissue than in any other organ examined, but also a notable association: samples from individuals with dementia at time of death showed significantly higher plastic concentrations than neurotypical controls. The authors were explicit about the limitation — correlation in postmortem tissue does not establish causation. But the association was both unexpected and reproducible, and it has since attracted substantial follow-up funding.

In April 2025, a study communicated through the American Heart Association found that stroke survivors had particularly high concentrations of microplastics in their carotid plaques, extending the NEJM cohort findings with a different patient population and a focus specifically on the stroke outcome. The literature is now accumulating faster than it can be synthesised.

Section IV

The Reckoning

There is currently no established medical method to remove microplastics from human tissue. Once embedded in arterial walls, neural tissue, or placental cells, the particles remain. Unlike some toxins — which the liver metabolises, the kidney filters, or immune macrophages engulf — plastic fragments are too stable, too diverse in chemistry, and too numerous for the body's clearance mechanisms to address. They are, by design, durable. That is precisely why we manufactured them.

The exposure pathway is equally difficult to interrupt. Plastic is in tap water and bottled water. It is in sea salt, honey, beer, fruits, vegetables, meat, and air. Heating food in plastic containers measurably accelerates leaching of both particles and chemical additives. Paper coffee cups lined with plastic shed particles into hot beverages. There is no diet or lifestyle choice that eliminates exposure — though some strategies reduce it: glass and stainless steel containers, filtered tap water, minimising plastic contact with hot food, and reducing ultraprocessed food consumption all lower daily intake by meaningful amounts.

The research community faces a problem that has no clean solution. The associations we can measure — cardiovascular risk, brain accumulation, dementia correlations, reproductive impairment in animal models — are real and growing more reproducible. What is not yet proven is causation at the human population level for most of these outcomes. We do not yet have a controlled longitudinal study demonstrating that reducing microplastic exposure measurably reduces disease risk. That study would require decades and an exposure contrast that may no longer exist on this planet.

In 2023, representatives from 175 countries began negotiating a global plastics treaty under United Nations auspices. As of early 2025, those negotiations remained active but contested — primarily by petrochemical-producing nations with economic interests in maintaining production volumes. A binding agreement to reduce plastic production at source, not merely improve recycling at the end, would represent the only structural intervention capable of bending the exposure curve. Whether it arrives before the contamination compounds further is not a scientific question. It is a political one. And the body, in the meantime, keeps accumulating.